all report title image

RESPIRATORY INHALERS MARKET ANALYSIS

Respiratory Inhalers Market, By Type (Manually Operated and Digitally Operated), By Product (Dry Powder Inhaler, Metered Dose Inhaler, Others), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Arterial Hypertension, Other), By End User (Hospitals & Clinics, Respiratory Care Center, Academic and Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI227
  • Pages :180
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Concentration and Competitive Landscape

Respiratory Inhalers Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Technological advancements in inhalers

Technological advancements in inhalers can drive the global respiratory inhalers market growth. Inhalers have increasingly become smart and digital with new features which help patients better manage their chronic respiratory conditions like asthma and COPD. Many new digital inhalers are equipped with sensors that can track usage data and send it via Bluetooth to a app in the patient's smartphone. This provides both patients and doctors real-time insights into medication adherence and symptoms. The data collection functionality is useful for doctors to monitor patient's condition remotely and tweak treatment plans accordingly. It also helps patients to take medications on time as dosage schedule and remaining timeline is visible on mobile apps. Some high-end smart inhalers also have in-built reminders and feedback systems to ensure proper inhalation technique. All these features are proving especially helpful for the growing elderly population suffering from multiple chronic conditions. The tracked usage data is also valuable for pharmaceutical companies to enhance therapeutics and services over time. On the product front, new single-dose dry powder inhalers that are easy-to-use and require less coordination during inhalation compared to older variants have witnessed huge demand. Furthermore, the introduction of affordable generic versions of blockbuster respiratory drugs has made treatment more accessible to patients globally. On May 2024, According to World Health Organization (WHO), the number of people suffering from asthma is estimated to increase by over 100 million globally by 2025. This growing disease burden coupled with technological upgrades in medication delivery methods can drive the respiratory inhalers market growth.

Key Players Insights
  • Koninklijke Philips N.V.
  • General Electric Healthcare
  • ResMed Inc.
  • Fisher & Paykel Healthcare
  • Medtronic
  • Boehringer Ingelheim
  • GlaxoSmithKline plc
  • AstraZeneca
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Hoffmann-La Roche Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Cipla Limited

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.